Be a Smart Investor
Monday, May 7, 2018
Sarepta Therapeutics (SRPT) Broke Out To A New High After Q1 Loss
Sarepta Therapeutics (SRPT) reported a first quarter adjusted loss of $0.28 after the close Thursday. Street expectations were for a loss of $0.32.
from RTT - Before the Bell https://ift.tt/2IjLfqa
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment